I expect 2026 to be a transition year with AEPS decline for Merck KGaA, but I see robust growth potential beyond. Read why ...

An Illinois jury in Cook County Circuit Court handed Merck a defense verdict on April 17 after fewer than two hours of ...

Many Americans are turning to AI tools for medical information, but there are conflicting views about the trustworthiness of ...

Introduction Incontinence is commonly experienced by adults who receive care support in a residential facility or in their own home. These individuals are at risk of developing incontinence‐associated ...

According to the Merck Manual of Diagnosis and Therapy, up to 3% of the U.S. population meets the criteria for antisocial personality disorder — meaning we've likely all had the unfortunate experience ...

Eosinophilic pneumonia is a lung condition characterized by elevated levels of a type of white blood cell called eosinophils in the lungs. 1 Eosinophilic pneumonia may be caused by cigarette smoking, ...

Merck & Co., Inc. remains the largest U.S. pharma company in 2025, driven by oncology and Keytruda, despite looming patent expiration risks. Keytruda accounts for over half of MRK's pharmaceutical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Merck Manuals is launching a new artificial intelligence-powered search tool designed to provide patients with streamlined access to trusted information and resources from its medical manuals.

Scott Stehlik, director of swine and poultry technical services for Merck Animal Health, presents a $50,000 donation to Jennifer Bloss, executive director for the National Professional Agricultural ...

In a new editorial from MerckManuals.com, Ashley B. Grossman, MD, University of Oxford; Fellow, Green-Templeton College, addresses common patient questions around Cushing syndrome. 1. What causes ...

Merck said its experimental shot designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial. The pharmaceutical giant could emerge as a new ...